📊 Carbon Goes Vertical, and Small-Cap IPOs Light Up the Board

A cannabinoid surge, a sustainable fuel breakthrough, and two $600M+ IPOs—here’s what just hit the radar.

In partnership with

Good Morning Investors,

Markets took a bold step into green and biotech territory as Incannex Healthcare jumped 61% on massive volume, riding investor interest in cannabinoid-based treatments for sleep and lung conditions. LanzaTech wasn’t far behindup 43% after scoring a major UK government grant to scale its waste-to-fuel tech.

On the biotech front, ImmunoPrecise surged 27% on tech breakthroughs and a strategic board addition, while Neumora spiked 24% ahead of its Q2 earnings. Meanwhile, Community Health slid 25% following a CEO exit and asset sales, and Faraday Future rode a Capitol Hill buzz to a 9% gain. And in IPO news, Accelerant Holdings and McGraw Hill each launched with over $600M in market cap, signaling a healthy appetite for new entrants.

Matthias Schneider
Editor at Analytica Investor

Subscribe to keep reading

This content is free, but you must be subscribed to Analytica Investor to continue reading.

Already a subscriber?Sign in.Not now